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Molecular typing of Leishmania (Leishmania) amazonensis and 
species of the subgenus Viannia associated with cutaneous and 
mucosal leishmaniasis in Colombia: A concordance study
Clemencia Ovalle-Bracho, Carolina Camargo, Yira Díaz-Toro, Marcela Parra-Muñoz
Centro Dermatológico Federico Lleras Acosta, E.S.E., Bogotá, D.C., Colombia
Introduction: Multilocus enzyme electrophoresis (MLEE) is the reference standard for the characterization 
of Leishmania species. The test is restricted to specialized laboratories due to its technical complexity, cost, 
and time required to obtain results. Polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP) is used to identify Leishmania species. 
Objective: To establish the concordance between the two tests as identifying methods for circulating 
species in Colombia.
Materials and methods: A total of 96 isolates from patients with cutaneous or mucosal leishmaniasis 
were selected and identified by MLEE and PCR-RFLP with miniexon and hsp70 as the molecular 
targets, which were used sequentially. Restriction enzymes HaeIII and BccI were similarly applied. 
Cohen’s kappa coefficient and the 95% confidence interval (CI) were calculated.
Results: The kappa coefficient and the 95% CI between MLEE and PCR-RFLP displayed “very good” 
concordance with a coefficient of 0.98 (CI95%: 0.98 to 1.00). The identified species were Leishmania 
Viannia braziliensis, Leishmania Viannia panamensis, Leishmania Viannia guyanensis and Leishmania 
Leishmania amazonensis. A total of 80 of the 96 isolates were sequenced and the results obtained by 
PCR-RFLP were confirmed.
Conclusion: Due to the concordance obtained between tests results with the amplification of the genes 
miniexon and hsp70, PCR-RFLP is proposed as an alternative for identifying circulating Leishmania 
species in Colombia.
Key words: Leishmania; leishmaniasis; molecular typing; isoenzymes; polymerase chain reaction; 
polymorphism, restriction fragment length.
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Tipificación molecular de Leishmania (Leishmania) amazonensis  y especies del subgénero Viannia 
asociadas a la leishmaniasis cutánea y la mucosa en Colombia: un estudio de concordancia
Introducción. La electroforesis de enzimas multilocus (Multilocus Enzyme Electrophoresis, MLEE) 
es el estándar de referencia para la tipificación de las especies de Leishmania. La prueba está 
restringida a laboratorios especializados por su complejidad técnica, sus costos y el tiempo necesario 
para obtener resultados. La PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length 
Polymorphism) se utiliza para tipificar especies de Leishmania.
Objetivo. Establecer la concordancia entre las dos pruebas como métodos de tipificación de las 
especies circulantes en Colombia.
Materiales y métodos. Se seleccionaron 96 aislamientos de pacientes con leishmaniasis cutánea o 
mucocutánea y se tipificaron mediante MLEE y PCR-RFLP con los blancos moleculares miniexon y 
hsp70 usados en serie. Las enzimas de restricción aplicadas fueron la HaeIII y la BccI, respectivamente. 
Se calculó el coeficiente kappa y un intervalo de confianza (IC) de 95 %.
Resultados. Se determinó que la concordancia fue “muy buena” al obtener un coeficiente de 0,98 (IC95%: 
0,98-1,00). Las especies identificadas fueron: Leishmania Viannia braziliensis, L. (V.) panamensis, L. 
(V.) guyanensis y L. (L,) amazonensis. De los 96 aislamientos, 80 se enviaron a secuenciación y se 
confirmaron los resultados obtenidos mediante PCR-RFLP.
Conclusión. Dada la concordancia obtenida con la PCR-RFLP amplificando los genes miniexon 
y hsp70, se propone esta prueba como alternativa para la tipificación de especies de Leishmania 
circulantes en Colombia.
Palabras clave: Leishmania; leishmaniasis; tipificación molecular; isoenzimas; reacción en cadena de 
la polimerasa; polimorfismo de longitud del fragmento de restricción.
doi: https://doi.org/10.7705/biomedica.v38i0.3632
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Leishmaniasis is a group of endemic diseases in 
98 countries, affecting approximately 12 million 
people, with approximately 350 million more at risk. 
These diseases are produced by a protozoan of the 
Leishmania genus with clinical manifestations in 
the skin, mucous membranes, and organs (1). The 
presentation of the disease, its evolution, and its 
response to treatment in the host vary according to 
the infective species. Therefore, identification of the 
diseases is relevant when determining the prognosis 
of the disease and when making an effective treat-
ment choice. Species identification also allows for 
an understanding of the epidemiological behavior 
of the disease and contributes to the formulation of 
the control and prevention strategies appropriate to 
each region (2-5).
Currently, multilocus enzyme electrophoresis (MLEE) 
is considered the reference standard for the identifi-
cation of Leishmania species due to its widespread 
use and ability to discriminate species in both 
the New and Old World (6-8). This methodology 
allows the characterization of the microorganisms 
by the electrophoretic mobility of a wide range 
of intracellular enzymes (9,10). Worldwide, nine 
reference centers provide species identification by 
MLEE, and only three of them are in the Americas 
(1). This, added to the complexity of the technique, 
limits the frequent application of this methodology 
to characterize Leishmania species in Colombia 
and the world (10-12).
Polymerase chain reaction (PCR) followed by an 
analysis of restriction fragment length polymor-
phism (RFLP) offers an alternative for identifying 
Leishmania species by analyzing the characteristic 
patterns of the different species obtained using 
restriction enzymes on amplified products of the 
genetic material of interest. This methodology has 
been expanded in the last two decades due to its 
speed in obtaining results, its ability to discriminate 
between species, and to adapt it to somewhat 
complex conditions regarding available technical 
resources, as well as the possibility of identifying 
Leishmania species directly from clinical samples 
(4,11,13,14).
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For identifying Leishmania species via PCR-
RFLP, different molecular targets have been used. 
Some of the most frequently used have been 
kinetoplast DNA (kDNA) (15-18), the GP63 gene 
(4), the β-tubulin gene (19), ITS rDNA (18,20), the 
miniexon gene (21-24), and the gene that encodes 
heat shock protein 70 (hsp70) (2,25).
Previous studies from our group have focused on 
identifying circulating species of Leishmania in 
Colombia by using MLEE, monoclonal antibodies 
and PCR with kDNA, ITS rDNA, miniexon and 
hsp70 as targets, with the last two being those that 
allow differentiation of all subgenus Leishmania and 
Viannia species circulating in Colombia (18,26-29).
Amplification of the miniexon gene permits to identify 
the species L. (L.) amazonensis, L. (L.) mexicana, 
and L. (L.) infantum by differences in amplified 
product size (22,23). When amplification is followed 
by restriction using the HaeIII enzyme, it is possible 
to identify L. (V.) braziliensis but not the complex L. 
(V.) panamensis/L. (V.) guyanensis (22-24,30). The 
hsp70 gene amplification followed by RFLP with the 
BccI enzyme allows to differentiate between L. (V.) 
panamensis and L. (V.) guyanensis (25,31,32).
The aim of this study was to establish the concor-
dance between PCR-RFLP using miniexon and 
hsp70 as molecular targets and the reference 
standard MLEE for the identification of circulating 
Leishmania species in Colombia.
Materials and methods
Type of design
We conducted a concordance study that used 
MLEE and PCR-RFLP for the identification of the 
Leishmania species circulating in Colombia.
Study population
Isolates came from patients diagnosed with cuta-
neous, diffuse and mucosal leishmaniasis who 
visited the Centro Dermatológico Federico Lleras 
Acosta E.S.E. between 1999 and 2011.
Sample
We included 96 samples out of the 800 available at 
the biological bank. The inclusion criteria was strains 
previously identified under the indirect fluorescent 
antibody test and classified like null phenotype.
Reference strains
The reference strains included L. (V.) braziliensis 
(MHOM/BR/75/M2903), L. (V.) panamensis (MHOM/ 
PA/71/LS94), L. (V.) guyanensis (MHOM/BR/75/
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M4147), L. (L.) amazonensis (IFLA/BR/67/PH8), 
and L. (L.) mexicana (MNCY/BZ/62/M379). The 
electrophoretic and restricted patterns of the refer-
ence strains were used to determine the species of 
the isolates.
Parasite culture
Parasites were cultured in Senekjie’s medium and 
incubated at 26°C until we obtained a primary cul-
ture. Subsequently, a mass culture was performed 
using Schneider’s medium supplemented with 10% 
fetal bovine serum (33).
Species identification
Identification by MLEE and PCR-RFLP were per-
formed from the same isolated sample. Samples 
were processed by different professionals for each 
of the tests. Isoenzyme identification was performed 
in a reference center of the Pan American Health 
Organization (PAHO).
Identification by MLEE
The preparation of the extract for analysis and 
the isoenzyme was performed according to the 
methods described by Saravia, et al. (34,35). 
Isoenzyme electrophoresis of the clinical isolates 
and reference strains was performed on a cellulose 
support according to the method described by 
Godfrey, et al. (36).
DNA extraction
The cetyltrimethylammonium bromide method was 
performed as described by Wagner, et al., in 1987 
and used for both the reference strains and the 
clinical isolates (37).
Miniexon gene PCR
For gene amplification we used the primers reported 
by Marfurt, et al. (22,23). Each PCR reaction 
contained 20 mM Tris-HCl pH 8.4; 50 mMKCl; 1 
mM MgCl2; 200 μMdATP, dCTP, dTTP and dGTP; 
0.5 μM of each primer (Fme 5´-TAT TGG TATGCG 
AAA CTT CCG-3´ and Rme 5´-ACA GAA ACT GAT 
ACT TAT ATA GCG-3´) and DMSO 6%, 2 μl of 
DNA at 10 ng/μl and 0.05 units of Taq Polymerase 
Platinum (Invitrogen, São Paulo, Brasil) at a final 
volume of 50 μl.
Amplification was performed with the following 
conditions: An initial DNA denaturation at 95°C 
for 8 minutes; 40 amplification cycles of 95°C for 
20 s, 55°C for 30 s and 72°C for 30 s; and a final 
extension cycle at 72°C for 5 minutes.
hsp70 gene PCR
Amplification was performed following the protocol 
proposed by García, et al. (25). Each PCR reaction 
contained 20 mMTris-HCl pH 8.4; 50 mMKCl; 2 mM 
MgCl2; 200 μMdATP, dCTP, dTTP and dGTP;0.4 
μM of each primer (hsp70 sen 5’-GAC GGT GCC 
TGC CTA CTT CAA-3’ and hsp70 ant 5’-CCG CCC 
ATG CTC TGG TAC ATC-3’); 10% DMSO; 2 μl of 
DNA at 10 ng/μl and 0.05 units of Taq Polymerase 
Platinum (Invitrogen, São Paulo, Brazil) at a final 
volume of 50 μl.
Amplification was performed using the following 
protocol: An initial DNA denaturation at 94°C for 
5 minutes; 33 amplification cycles at 94°C for 1 
minute, 64°C for 1 minute and 72°C for 3 minutes; 
and a final extension cycle at 72°C for 10 minutes.
Visualization of the miniexon and hsp70 PCR 
products
Amplicons of the miniexon and hsp70 genes were 
analyzed by electrophoresis in 1% and 2% agarose 
gels, respectively. For the identification of species 
through PCR-RFLP, the molecular weights of the 
amplicons from the miniexon gene must be con-
sidered: 308 bp for L. (L.) mexicana, 283 bp for L. 
(L.) amazonensis, and 418 bp for the L. (L.) chagasi 
control, and between 255 and 227 bp for the Viannia 
subgenus (22, 23). The hsp70 gene presents a 
1422-bp band for the Viannia subgenus (38).
Restriction fragment length polymorphism (RFLP)
Samples showing an amplification profile of the 
miniexon gene compatible with the Viannia sub-
genus were subjected to restriction with the HaeIII 
enzyme (Invitrogen, São Paulo, Brazil). 
The hsp70 gene of the samples that were identified 
as L. (V.) panamensis/L. (V.) guyanensis through 
the miniexon gene PCR-RFLP was also amplified 
and digested with the BccI enzyme (New England 
Biolabs, Ipswich, England). 
Amplicons of the miniexon and hsp70 genes were 
purified using QIA quick PCR Purification kits 
(Qiagen, Düsseldorf, Germany). A total of 12.5 μl 
of purified PCR product was used for the digestion, 
with the addition of 1.4 μl of reaction buffer and 0.5 
μl of restriction enzymes HaeIII (10 U/μl) and BccI 
(10 U/μl); the mix was incubated at 37°C for 120 
minutes and at 45 volts. 
Restriction products were analyzed by electro-
phoresis using high-resolution 2.5% agarose gels 
(Sigma-Aldrich, St. Louis, Missouri, USA) at 2.5 V/
cm for 1.5 hours; a 100-bp molecular-weight marker 
was used (Bioline, London, England).
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The samples that presented a restriction pattern of 
two bands of 108 and 118 bp with the HaeIII enzyme 
were identified as L. (V.) braziliensis. Amplicons that 
did not show a restriction pattern were identified as 
L. (V.) panamensis/L. (V.) guyanensis. 
The restriction products obtained through the BccI 
enzyme in the reference strains L. (V) panamensis 
(MHOM/PA/71/LS94) and L. (V) guyanensis (MHOM/ 
BR/75/M4147) showed the following patterns: Two 
bands of 428 and 890 bp and three bands of approxi-
mately 346, 428 and 544 bp. Species of clinical 
isolates were determined based on the restriction 
patterns obtained with reference strains.
Sequencing
We selected 80 isolates by simple random sampling 
and sequenced them to confirm the species identi-
fied by PCR and PCR-RFLP, including the samples 
identified as L. (V.) panamensis, L. (V.) braziliensis, 
L. (V.) guyanensis, and L. (V.) amazonensis. 
For sequencing we used a BigDye Terminator, 
v3.1, Cycle Sequencing Kit (Applied Biosystems, 
Foster City, CA, USA) and an Applied Biosystems 
3730xl DNA Analyzer system (Applied Biosystems, 
Foster City, CA, USA). For the analysis we used 
the software Geneious Pro 5.5.6 (Biomatters Ltda, 
Auckland, New Zealand) to align the sequences 
obtained with the sequences available at NCBI of 
the particular genes of the species of interest.
Statistical analysis
The results of the MLEE and PCR-RFLP of the 
species identified were recorded in an Excel data-
base (Microsoft Office XP). Cohen’s kappa coeffi-
cient and the 95% CI were calculated using the 
software Stata®, version 13 (Stata Corp LP, College 
Station, Texas, USA) to determine the concordance 
between the MLEE and PCR-RFLP results.
Ethical considerations
This study was classified as safe and approved 
by Centro Dermatológico Federico Lleras Acosta 
E.S.E. Ethical Committee for the use of cryopre-
served samples according to the ethical guidelines 
established by the Ethics Committee in Research, 
which are based on the Declaration of Helsinki and 
current Colombian regulations.
Results
The identification of the species for the isolates was 
performed according to the results obtained by PCR, 
PCR-RFLP and MLEE: L. (V.) braziliensis: 63.5%, L. 
(V.) panamensis: 21.9%, L. (V.) guyanensis: 5.2% 
and L. (L.) amazonensis: 9.4%. Sequencing con-
firmed the results obtained by PCR and PCR-
RFLP. Figures 1 and 2A show PCR–miniexon 
gene and PCR-hsp70 gen amplification products 
from different Leishmania reference strains and 
clinical samples, respectively. The figure 2B shows 
restriction endonuclease DNA fragment patterns 
from amplicons of the PCR-hsp70 gene using BccI 
enzyme. Table 1 shows the identification results 
obtained by MLEE, miniexon gene PCR-RFLP, and 
hsp70 gene PCR-RFLP, and table 2 shows the 
results obtained by sequencing.
The concordance between the results of Leishmania 
species identification by PCR-RFLP and MLEE was 
“very good” according to the scale of Landis, et al. 
(39), for obtaining a kappa of 0.98 (CI95%: 0.98-1).
Among the 96 samples analyzed by both molecular 
tests (miniexon gene PCR-RFLP and hsp70 gene 
PCR-RFLP) and by MLEE, only one discord-
ant result was observed. One of the isolates 
was identified through molecular tests as L. (V.) 
braziliensis but as L. (V.) panamensis by MLEE.
We obtained 96 isolates from patients whose ages 
ranged between 1.4 and 73 years and who had 
been diagnosed with cutaneous, diffuse cutaneous 
or mucosal leishmaniasis.
The patients came from 51 municipalities endemic for 
leishmaniasis in 15 different departments: Antioquia 
(n=1), Boyacá (n=4), Caldas (n=4), Caquetá (n=15), 
Casanare (n=2), Cundinamarca (n=24), Guainía 
(n=1), Guaviare (n=6), Meta (n=21), Nariño (n=1), 
Risaralda (n=1), Santander (n=4), Tolima (n=6), 
Valle del Cauca (n=2), and Vichada (n=4) (figure 3).
1
2000 bp
1000 bp
300 bp
2 3 4 5 6 7 8 9 10 11 12 13 14 15
Figure 1. A. Line 1, molecular weight marker; Line 2, L. (V.) 
braziliensis reference strain DNA; Line 3, L. (V.) panamensis 
reference strain; Line 4, L. (V.) guyanensis reference strain; Lines 
5-8, DNA from clinical samples of leishmaniasis cases typed as 
Leishmania Viannia subgenus; Lines 9-10 L. (L.) amazonensis 
reference strain; Lines 11-12, L. (L.) mexicana reference strain; 
Lines 13-14, L. (L.) infantum; Line 15, negative control
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Discussion
According to the criteria of Landis, et al. (39), this 
study achieved a “very good” concordance between 
MLEE and PCR-RFLP of the miniexon and hsp70 
genes for characterizing circulating Leishmania 
species in Colombia from clinical isolates. These 
results indicate that those obtained using PCR-
RFLP for the species under study are equivalent 
to the results obtained using MLEE, which is con-
sidered the reference standard (1,6). The tests were 
applied on samples from the five geographical 
regions of the country, suggesting that it is possible 
to identify species despite the intraspecies varia-
bility associated with geographical distribution.
MLEE is a useful technique for characterizing spe-
cies, as it permits the analysis of genetic variability 
between and among species, as well as their 
taxonomies and phylogenies (40,41). However, this 
methodology does not permit the direct identifica-
tion of clinical specimens, the culture is required 
and it has low sensibility for samples from patients 
with mucosal and chronic cutaneous leishmaniasis, 
which prevents obtaining large amounts of parasi-
tes. Besides, MLEE is technically demanding and 
requires prolonged times for obtaining results 
(10-12,41). An alternative to discriminate between 
Leishmania species is PCR-RFLP, a widely used 
test that is performed with different molecular targets 
to determine the ability to differentiate species (42).
The miniexon and hsp70 genes were selected to 
identify circulating species in Colombia as they 
have several advantages: The number of copies of 
the genes allows for good test sensitivity, and these 
genes have been validated on a global scale with 
Old and New World species.
Recently, van der Auwera, et al., concluded 
after the analysis of several publications that the 
miniexon and hsp70 genes, compared to other 
molecular targets, exhibit the best resolution to 
identify medically relevant Leishmania species (43). 
This claim is supported by experimental studies of 
the miniexon gene performed by Marfur, et al., as 
well as studies performed by Serin, et al., who 
evaluated the functionality of the miniexon gene as 
a phylogenetic marker of 17 species of the New 
Table 1. Typing results of 96 isolates of Leishmania spp. by 
MLEE and PCR-RFLP methods
MLEE PCR-RFLP 
miniexon gene
PCR-RFLP
hsp70 geneƗ
L. (V.) braziliensis 60 61 -
L. (V.) panamensis 22 - 21
L. (V.) guyanensis   5 -   5
L. (V.) panamensis/L. 
(V.) guyanensis
- 26 -
L. (L.) amazonensis   9   9 -
Total 96 96 26
Ɨ: Method applied only to 26 samples classified as L. (V.) panamensis/L. 
(V.) guyanensis by PCR-RFLP with the miniexon gene
Table 2. Typing results of 80 isolates of Leishmania spp. by 
MLEE and PCR-RFLP miniexon/hsp70 methods evaluated by 
sequencing
Sequencing MLEE PCR-RFLP 
miniexon/hsp70
L. (V.) braziliensis 47 46 47
L. (V.) panamensis 20 21 20
L. (V.) guyanensis   4   4   4
L. (L.) amazonensis   9   9   9
Total 80 80 80
1
2000 bp
1000 bp
300 bp
1000 bp
300 bp
500 bp
2 3 4 5 6 1 2 3 4 5 67 8 9A. B.
Figure 2. A. Line 1, molecular weight marker; Line 2, negative control; Line 3 L. (V.) panamensis reference strain DNA; Line 4, L. (V.) 
guyanensis reference strain DNA; Lines 5-8, DNA from clinical samples of leishmaniasis cases; Line 9, clinical sample from patient 
with suggested diagnosis of mucosal leishmaniasis and rhinoscleroma confirmed diagnosis. B. Line 1, molecular weight marker; 
Line 2, L. (V.) guyanensis reference strain; Line 3, clinical sample typed as L. (V.) guyanensis; Line 4, L. (V.) panamensis reference 
strain; Lines 5-6, clinical samples typed as L. (V.) panamensis
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and the Old World (22-24). The hsp70 gene has 
been evaluated for almost all circulating species 
in the world, with results that demonstrate its 
discriminatory capacity (28,32,44).
In our study, we identified L. (V.) braziliensis using 
PCR-RFLP, and L. (L.) amazonensis using only 
PCR based on amplicon size, results that were con-
firmed by sequencing. In Colombia, even though the 
prevalent species are associated with the Viannia 
subgenus, L. (L.) amazonensis recently was asso-
ciated with cutaneous, diffuse cutaneous, and 
mucosal leishmaniasis. PCR of the miniexon gene 
allows the identification of L. (L.) amazonensis, L. 
(L.) mexicana, and L. (L.) chagasi only by amplicon 
size. This approach is very useful and less expen-
sive than other methods that require additional 
tests such as RFLP or sequencing.
The hsp70 gene has also been extensively evalu-
ated in Old and New World species. García, et 
al., were the first to identify its functionality to 
diagnose and differentiate species from the sub-
genera Leishmania and Viannia, complemented 
with techniques such as RFLP and sequencing 
(29,32,38,45-48).
This technique has also proven to be useful in 
differentiating species from the L. guyanensis 
complex, which includes L. (V.) panamensis and L. 
(V.) guyanensis. These species are of great clinical 
and epidemiological interest in Colombia because 
L. (V.) guyanensis was associated with the largest 
epidemic of leishmaniasis in the country. This 
species also presents differences in the in vitro 
susceptibility response to drugs compared to other 
species of the Viannia subgenus (49,50).
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Figure 3. Distribution of Leishmania species identified by PCR-RFLP with miniexon and hsp70as molecular targets. Map done using 
ArcGis vr. 10.2 program; the altitude was obtained from the WorldClim database with 1 km resolution (http://www.worldclim.org/). 
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In our study, hsp70 gene amplification and RFLP 
using the enzyme BccI were very useful, as they 
allowed discrimination between L. (V.) panamensis 
and L. (V.) guyanensis. The results obtained in the 
concordance analysis between the two tests suggest 
that they are equivalent for identifying the species 
circulating in Colombia. Our results are consistent 
with those obtained by da Silva, et al., who found 
an overall concordance between MLEE and PCR-
RFLP of the hsp70 gene of the circulating species in 
Brazil, based on which the authors concluded that 
the latter method can replace MLEE in the routine 
identification of Leishmania species (51).
Another method recently used to identify species is 
the high-resolution analysis of dissociation using the 
hsp70 gene, which has demonstrated good agree-
ment with PCR-RFLP and MLEE (52). Cardoso 
da Graça, et al., compared the molecular targets 
ITS, G6PD and hsp70 with MLEE, and found very 
good concordance between the methodologies for 
the identification of L. (L.) amazonensis, L. (L.) 
infantum, L. (V.) guyanesis, L. (L.) lanzoni, L. (V.) 
naiffi, and L. (L.) shawi, but discordance for the iden-
tification by MLEE of L. (V.) braziliensis (53), which 
was the only dissenting finding of the current study.
Several hypotheses have been proposed to explain 
the difference between the identification results of 
the various methodologies, including the possibility 
of mixed infection, variation in the patterns accord-
ing to the markers used, and the similarity between 
species of the Viannia subgenus (53,54).
The results indicate that the PCR-RFLP of the 
miniexon and hsp70 genes permit the identification 
of circulating species in the country. This test could 
be used in more laboratories compared to MLEE 
because it is technically simpler and the cost is 
50% less than for MLEE. This work includes the 
largest number of samples reported in the country, 
identified by molecular tests and with a wide geo-
graphical distribution.
The test is restricted to native species, but it would 
be possible to expand its spectrum using other 
restriction enzymes to identify new circulating or 
imported species. Here we propose an identifica-
tion algorithm for the Leishmania species that are 
circulating in Colombia (figure 4).
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L. (V.) braziliensis L. (V.) panamensis/ L. (V.) guyanensis
DNA extractionPatient sample
(Isolated, aspirate, biopsy, smear)
Figure 4. Identification algorithm of Leishmania species with miniexon and hsp70 as molecular targets
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